Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Capital Expenditures (2018 - 2025)

Health Catalyst (HCAT) has disclosed Capital Expenditures for 8 consecutive years, with $664000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures fell 5.82% year-over-year to $664000.0, compared with a TTM value of $1.1 million through Sep 2025, up 383.84%, and an annual FY2024 reading of $1.6 million, up 22985.71% over the prior year.
  • Capital Expenditures was $664000.0 for Q3 2025 at Health Catalyst, up from -$639000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $5.9 million in Q1 2021 and bottomed at -$8.8 million in Q4 2021.
  • Average Capital Expenditures over 5 years is $184947.4, with a median of $356000.0 recorded in 2022.
  • Peak annual rise in Capital Expenditures hit 7538.96% in 2021, while the deepest fall reached 993.33% in 2021.
  • Year by year, Capital Expenditures stood at -$8.8 million in 2021, then soared by 82.6% to -$1.5 million in 2022, then skyrocketed by 36.71% to -$974000.0 in 2023, then surged by 142.4% to $413000.0 in 2024, then surged by 60.77% to $664000.0 in 2025.
  • Business Quant data shows Capital Expenditures for HCAT at $664000.0 in Q3 2025, -$639000.0 in Q2 2025, and $670000.0 in Q1 2025.